Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #35,501 to #35,550.
- Neoplastic meningitis cost-effectiveness of therapy (2 revisions)
- Neoplastic meningitis future or investigational therapies (2 revisions)
- Neoplastic meningitis secondary prevention (2 revisions)
- Neorickettsia (2 revisions)
- Neosalvarsan (2 revisions)
- Neovascularization (2 revisions)
- Nepenthes boschiana (2 revisions)
- Nepenthes distillatoria (2 revisions)
- Nephritic syndrome case study one (2 revisions)
- Nephrocalcinosis CT (2 revisions)
- Nephrocalcinosis historical perspective (2 revisions)
- Nephrocalcinosis overview (2 revisions)
- Nephrocalcinosis pathophysiology (2 revisions)
- Nephrogenic diabetes insipidus (patient information) (2 revisions)
- Nephrogenic diabetes insipidus history and symptoms (2 revisions)
- Nephrogenic diabetes insipidus laboratory findings (2 revisions)
- Nephrogenic diabetes insipidus natural history, complications and prognosis (2 revisions)
- Nephrogenic diabetes insipidus primary prevention (2 revisions)
- Nephron (2 revisions)
- Nepinalone (2 revisions)
- Nerve agent (2 revisions)
- Nessler's reagent (2 revisions)
- Netrin 1 (2 revisions)
- Network effect (2 revisions)
- Neural cell adhesion molecule (2 revisions)
- Neural tube defect (2 revisions)
- Neuralgia epidemiology and demographics (2 revisions)
- Neuralgia laboratory findings (2 revisions)
- Neuralgia other diagnostic studies (2 revisions)
- Neuregulin 3 (2 revisions)
- Neurobiology (2 revisions)
- Neuroblastoma primary prevention (2 revisions)
- Neuroblastoma secondary prevention (2 revisions)
- Neurocardiology (2 revisions)
- Neurochemistry (2 revisions)
- Neuroendocrine tumors other diagnostic studies (2 revisions)
- Neurofibrillary tangle (2 revisions)
- Neurofibroma future or investigational therapies (2 revisions)
- Neurofibromatosis type 1 echocardiography and ultrasound (2 revisions)
- Neurofibromatosis type 1 electrocardiogram (2 revisions)
- Neurofibromatosis type 1 interventions (2 revisions)
- Neurofibromatosis type 1 other diagnostic studies (2 revisions)
- Neurofibromatosis type 1 overview (2 revisions)
- Neurofibromatosis type 1 primary prevention (2 revisions)
- Neuroglycopenia history and symptoms (2 revisions)
- Neurogranin (2 revisions)
- Neuroimaging (2 revisions)
- Neuromarketing (2 revisions)
- Neuromedin B receptor (2 revisions)
- Neuromedin N (2 revisions)